Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Assesment of Risk Factors for Tardive Dyskinesia (OPEN ACCESS)
2
x
$
0.00
Misdiagnosis of Catatonia (OPEN ACCESS)
1
x
$
0.00
The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports (OPEN ACCESS)
1
x
$
0.00
Case Report: A Case of Intellectual Disability with Inappropriate and Challenging Sexual Behavior that was Treated with GNRH Analogues (OPEN ACCESS)
1
x
$
0.00
Use of Clozapine in the General Hospital (OPEN ACCESS)
1
x
$
0.00
The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
1
x
$
30.00
View Cart
Checkout
Home
schizophrenia
“The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Takefumi Suzuki – Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
$
30.00
Add to cart
Details
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Previous
1
…
3
4
Page load link
Go to Top
